(c) 2024 PillSync.com

ezetimibe 10 MG Simvastatin 40 MG Oral Tablet

1 INDICATIONS AND USAGE Ezetimibe and Simvastatin Tablets Ezetimibe and simvastatin tablets are a combination of simvastatin and ezetimibe indicated: As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce elevated LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). Simvastatin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, are indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. Ezetimibe and simvastatin tablets are a combination of ezetimibe, a dietary cholesterol absorption inhibitor, and simvastatin, an HMG-CoA reductase inhibitor (statin) indicated: ( 1 ) As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C lowering therapies to reduce LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). Simvastatin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events.

amneal pharmaceuticals ny llc


4 years ago OVAL WHITE AA72 ezetimibe 10 MG  Simvastatin 40 MG Oral Tablet

OVAL WHITE AA72

16 HOW SUPPLIED/STORAGE AND HANDLING

EZETIMIBE AND SIMVASTATIN tablets, 10/10 mg , are supplied as white to off-white, capsule shaped tablets, debossed with “AA 70” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 69238-1155-3 Bottles of 90: NDC 69238-1155-9

EZETIMIBE AND SIMVASTATIN tablets, 10/20 mg , are supplied as white to off-white, capsule shaped tablets, debossed with “AA 71” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 69238-1156-3 Bottles of 90: NDC 69238-1156-9

EZETIMIBE AND SIMVASTATIN tablets, 10/40 mg , are supplied as white to off-white, capsule shaped tablets, debossed with “AA 72” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 69238-1157-3 Bottles of 90: NDC 69238-1157-9

EZETIMIBE AND SIMVASTATIN tablets, 10/80 mg , are supplied as white to off-white, capsule shaped tablets, debossed with “AA 73” on one side and plain on the other side. They are available as follows: Bottles of 30: NDC 69238-1158-3 Bottles of 90: NDC 69238-1158-9 Storage Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Keep container tightly closed.


More pills like OVAL AA72

Related Pills

ezetimibe 10 MG Simvastatin 80 MG Oral Tablet

Amneal Pharmaceuticals NY LLC

ezetimibe 10 MG Simvastatin 20 MG Oral Tablet

Amneal Pharmaceuticals NY LLC

ezetimibe 10 MG Simvastatin 10 MG Oral Tablet

Amneal Pharmaceuticals NY LLC

ezetimibe 10 MG Simvastatin 40 MG Oral Tablet

amneal pharmaceuticals ny llc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site